| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/10/2010 | WO2010054324A3 Methods for treating clinical conditions associated with lipoprotein lipase activity |
| 09/10/2010 | WO2010048446A3 Modulation of axon degeneration |
| 09/10/2010 | WO2010030180A3 Peptide formulations and uses thereof |
| 09/10/2010 | CA2754655A1 Novel antiviral agent |
| 09/10/2010 | CA2754501A1 Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects |
| 09/10/2010 | CA2754482A1 Compositions and methods for modulation of cell migration |
| 09/10/2010 | CA2754461A1 Temperature sensitive mutants of matrix metalloprotease 1 and uses thereof |
| 09/10/2010 | CA2754423A1 Clostridial toxin to improve ejaculate |
| 09/10/2010 | CA2754399A1 Novel uses of fibrinogen |
| 09/10/2010 | CA2754251A1 Insulin formulations for rapid uptake |
| 09/10/2010 | CA2754226A1 Method and material for site activated complexing of biologic molecules |
| 09/10/2010 | CA2754119A1 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 09/10/2010 | CA2754065A1 Methods of inhibiting photoreceptor apoptosis |
| 09/10/2010 | CA2754044A1 Protease for wound conditioning and skin care |
| 09/10/2010 | CA2753461A1 Peptide for the prophylactic or therapeutic treatment of skin tumours in initial stages |
| 09/10/2010 | CA2752890A1 Method for preventing and treating hyperpermeability |
| 09/10/2010 | CA2750911A1 Compositions and methods |
| 09/09/2010 | US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/09/2010 | US20100227850 Methods for preventing and treating microbial infections by modulating transcription factors |
| 09/09/2010 | US20100227825 Peptides and peptide mimetics to treat cancer |
| 09/09/2010 | US20100227824 Pharmaceutical peptides for the treatment of inflammatory diseases |
| 09/09/2010 | US20100227823 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 09/09/2010 | US20100227822 Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| 09/09/2010 | US20100227821 Monitoring and modulating hgf/hgfr activity |
| 09/09/2010 | US20100227820 Effect of Porcine Sheath Proteins on the Regeneration Activity of Periodontal Ligament |
| 09/09/2010 | US20100227819 Serum-Free Cell Culture Medium for Mammalian Cells |
| 09/09/2010 | US20100227818 Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor For The Prevention Of Neutropenia |
| 09/09/2010 | US20100227817 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 09/09/2010 | US20100227816 Use of GLP-1 Analogues for the Treatment of Disorders Associated with Dysfunctional Synaptic Transmission |
| 09/09/2010 | US20100227815 Site-specific pegylated linear salmon calcitonin analogues |
| 09/09/2010 | US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 09/09/2010 | US20100227813 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia |
| 09/09/2010 | US20100227812 Method of supplementing the diet and ameliorating oxidative stress |
| 09/09/2010 | US20100227811 Farnesylamine derivatives and methods of use |
| 09/09/2010 | US20100227810 Method for diagnosing staphylococcal infections |
| 09/09/2010 | US20100227809 Combination treatment for metabolic disorders |
| 09/09/2010 | US20100227808 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 09/09/2010 | US20100227807 Use of Gelsolin to Diagnose and Treat Inflammatory Desease (Stossel) |
| 09/09/2010 | US20100227806 Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment |
| 09/09/2010 | US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases |
| 09/09/2010 | US20100227804 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 09/09/2010 | US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides |
| 09/09/2010 | US20100227801 Pharmaceutical compositions |
| 09/09/2010 | US20100227800 Triazole derivatives as kinase inhibitors |
| 09/09/2010 | US20100227799 Simultaneous photodynamic therapy and photo induced polymerization |
| 09/09/2010 | US20100227798 Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 09/09/2010 | US20100227797 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives |
| 09/09/2010 | US20100227796 Insulin Derivatives |
| 09/09/2010 | US20100227795 Insulin formulations for rapid uptake |
| 09/09/2010 | US20100227794 Smart contrast agent and method for detecting transition metal ions and treating related disorders |
| 09/09/2010 | US20100227793 Compositions and Methods for Treating Amyotrophic Lateral Sclerosis |
| 09/09/2010 | US20100227792 Phospholipid and protein tablets |
| 09/09/2010 | US20100227791 Compounds Having Antitumor Activity |
| 09/09/2010 | US20100227354 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/09/2010 | US20100227005 Methods to treat and/or prevent mucositis |
| 09/09/2010 | US20100226995 Microencapsulated bioactive agents for oral delivery and methods of use thereof |
| 09/09/2010 | US20100226990 Method of Producing Porous Microparticles |
| 09/09/2010 | US20100226985 Viscoelastic aqueous gels comprising microspheres |
| 09/09/2010 | US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 09/09/2010 | US20100226967 Imaging and therapeutic method using progenitor cells |
| 09/09/2010 | US20100226965 Compositions & methods for wound healing |
| 09/09/2010 | US20100226961 Cross-linked bioactive hydrogel matrices |
| 09/09/2010 | US20100226960 Natural biodegradable matrices and uses thereof |
| 09/09/2010 | US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226919 Antitumoral Treatments |
| 09/09/2010 | US20100226918 Pyrrole derivatives as p2y12 antagonists |
| 09/09/2010 | US20100226916 Compositions and methods for treating ocular diseases and conditions |
| 09/09/2010 | US20100226915 AGER-Peptides and Use Thereof |
| 09/09/2010 | US20100226911 Treating or preventing extracellular matrix build-up |
| 09/09/2010 | US20100226910 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 09/09/2010 | US20100226909 Method And Apparatus For Producing Autologous Thrombin |
| 09/09/2010 | US20100226908 Compositions for promoting wound healing and treating psoriasis |
| 09/09/2010 | US20100226907 Purification of butyrylcholinesterase using membrane adsorption |
| 09/09/2010 | US20100226906 Recombinant poly-glutamic acid depolymerases |
| 09/09/2010 | US20100226905 Pharmaceutical composition for preventing and treating restenosis comprising peroxiredoxin 2 protein as an active ingredient and composition for screening therapeutics of restenosis comprising peroxiredoxin 2 gene or its protein product, and method for screening th |
| 09/09/2010 | US20100226904 Organic chewable supplement |
| 09/09/2010 | US20100226891 Surface expression vector for fusion protein of myo-2 peptide multimer and myostatin, and microorganism transformed by thereof |
| 09/09/2010 | US20100226889 HCV Combination Therapies |
| 09/09/2010 | US20100226888 Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde |
| 09/09/2010 | US20100226887 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis |
| 09/09/2010 | US20100226886 Combinations of MTP Inhibitors with Cholesterol Absorption Inhibitors or Interferon for Treating Hepatitis C |
| 09/09/2010 | US20100226885 Method of treating hepatitis c patients |
| 09/09/2010 | US20100226884 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) |
| 09/09/2010 | US20100226883 Linked diimidazole derivatives |
| 09/09/2010 | US20100226882 Linked diimidazole antivirals |
| 09/09/2010 | US20100226881 PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY |
| 09/09/2010 | US20100226880 Treatment with anti-vegf antibodies |
| 09/09/2010 | US20100226879 Heterocyclic antiviral compounds |
| 09/09/2010 | US20100226878 Methods of inhibiting photoreceptor apoptosis |
| 09/09/2010 | US20100226852 Clk-peptide and slk-peptide |
| 09/08/2010 | EP2226385A1 Human Coagulation Factor VII Variants |
| 09/08/2010 | EP2226382A1 Protease for wound conditioning and skin care |
| 09/08/2010 | EP2226332A1 Mycobacterium tuberculosis epitopes and methods of use thereof |
| 09/08/2010 | EP2226085A1 Anti-angiogenic compositions and methods of use |
| 09/08/2010 | EP2226080A1 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 09/08/2010 | EP2226079A2 Stem cell derived paracrine factor SFRP2 for use in reducing cell death |
| 09/08/2010 | EP2225389A1 Sm-protein based secretion engineering |
| 09/08/2010 | EP2225271A2 New non-selective somatostatin analogues |
| 09/08/2010 | EP2225261A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |